1st part home work

While interviewing and examining a 17-year-old male, you discover a white patch on his buccal mucosa and slanting palpebral fissures in his eyes. He also states during the interview that he plays baseball and is hoping to earn an athletic scholarship to college.

· What do you suspect? What kind of client teaching is appropriate in this situation?

· Discuss appropriate educational materials for health promotion and disease prevention

· When would slanting palpebral fissures be normal?

· While performing a retinal examination on this patient, you discover that the margins of the optic disc become blurred and indistinct. What further testing would be required? Why?

Second part student post/I needs answer to this post base on the homework

Week 2 physical assessment 17 year old

Joh

Symptoms and Treatment

       Buccal mucosa is the inner lining of the lips and cheeks. Presence of white patches in the mouth of the patient could be as a result of irritation of the walls of the mouth cavity. This white patch is hard to come off and mainly attaches itself to the buccal mucosa. This condition is prevalent in tobacco and alcohol users. The patient is probably a smoker; if this is true, he needs to desist from smoking to avoid further irritation of the mouth walls which is a good disease prevention measure. Most teenagers of the patient’s age are likely to engage in smoking an activity which they do as fun. The patient should find other alternatives to smoking such as taking snacks and being with the right company in sports to ensure he succeeds in his quest of securing a scholarship.

      The palpebral fissure is the meeting point of the lower and upper eyelids. Slanting of palpebral fissures occurs normally on Asians which is a probable indication of the patient’s descent. The slanting of palpebral fissures is prevalent in people suffering from downs syndrome which has not been stated by the patient. More than 80% of the patients with Down’s syndrome suffer from palpebral fissure (“Down Syndrome (Trisomy 21)”, 2018).